Maternal antibody at delivery protects neonates from early onset group B streptococcal disease.
about
Group B Streptococcus vaccine: state of the artCorrelates of Protection for M Protein-Based Vaccines against Group A StreptococcusTransfer of Maternal Antimicrobial Immunity to HIV-Exposed Uninfected NewbornsGroup B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countriesAssociation between functional antibody against Group B Streptococcus and maternal and infant colonization in a Gambian cohort.Current management and long-term outcomes following chorioamnionitis.Anti-group B Streptococcus antibody in infants born to mothers with human immunodeficiency virus (HIV) infectionAntibody-mediated complement C3b/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border.Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial.Immune Responses to Invasive Group B Streptococcal Disease in Adults.Risk factors for group B streptococcal disease in neonates of mothers with negative antenatal testing.Neonatal Group B Streptococcal Disease in Otherwise Healthy Infants: Failure of Specific Neonatal Immune ResponsesOpsonophagocytic Antibodies to Serotype Ia, Ib, and III Group B Streptococcus among Korean Infants and in Intravenous Immunoglobulin Products.Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants.Group B streptococcal infections in the newborn infant and the potential value of maternal vaccination.Immunization During Pregnancy: Impact on the Infant.Immunological Outcomes of Antibody Binding to Glycans Shared between Microorganisms and Mammals.Mucosal vaccination promotes clearance of Streptococcus agalactiae vaginal colonization.A Time to Save.The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.Role of HIV exposure and infection in relation to neonatal GBS disease and rectovaginal GBS carriage: a systematic review and meta-analysis.Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy.Status of group B streptococcal vaccine development.Protective effect of Group B Streptococcus type-III polysaccharide conjugates against maternal colonization, ascending infection and neonatal transmission in rodent models.Group B Streptococcal Colonization, Molecular Characteristics, and Epidemiology.The Impact of IgG transplacental transfer on early life immunity
P2860
Q26796438-994C64E0-BBFF-4ADD-84EF-1E0CCA90411AQ27009175-7F28D61F-33A9-451E-AD86-14FA571F371BQ28070259-C001065D-7D1D-45D7-BCC2-8D1B65D19B65Q28075884-A1E0C5EA-C323-4D4E-B4AE-8FFC9F22D815Q33689195-8B6943F4-0723-4B61-94B3-B5E7EE2FD049Q34624861-122F310E-E677-4FED-8096-664F4D384E90Q35042473-2C59C614-4120-42DC-9E2C-A65FA3D7FB58Q35122775-E1BF7B2E-E06E-41EE-A782-C6AB1CA8EF99Q36809473-218B2F41-3DC2-4308-B49E-66E254A74392Q37382005-31420117-8D3F-4866-9B5A-73DCA8ADED96Q37614189-1BC9C477-FC48-480F-BFCB-FED25A896DFBQ37683149-2EDC310B-FFFD-485B-BD3F-029F15BEBA70Q37740442-95A9D2D0-3044-44BE-8300-C722D67BBF63Q38253017-A0C5A12A-DA35-4487-A81D-902666F52929Q38570903-B7E13A7B-C151-498B-A375-61BF3BC803DEQ38683189-4B86AA2B-0ED9-4D4D-8206-5992B1068C84Q39013747-6DDEE205-1063-4090-BC3F-699C083A12C4Q40344808-D7E3041C-5474-4DE6-A2E7-CD5BD4E8345DQ40378410-141BB967-D120-4EC8-9878-4858C3EB6428Q40617396-BEC6DBC5-362F-4CB2-AD2F-84B7C87EDD25Q45397507-11D5FAB5-D994-4D31-938D-E1C6A69BA0D6Q46987999-6A622CFB-88C2-4A74-8B09-B60976206DECQ48041915-DB03803F-DE44-4896-A845-350BF7640358Q50129993-99025A1D-9C22-49FB-9A89-95941AB88036Q52624533-D37D1147-3FD3-4C3F-AC66-4E8A8532FA76Q56505186-01768FAD-A232-4AB4-AB6E-F7302AC4DE4D
P2860
Maternal antibody at delivery protects neonates from early onset group B streptococcal disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Maternal antibody at delivery ...... group B streptococcal disease.
@en
Maternal antibody at delivery ...... group B streptococcal disease.
@nl
type
label
Maternal antibody at delivery ...... group B streptococcal disease.
@en
Maternal antibody at delivery ...... group B streptococcal disease.
@nl
prefLabel
Maternal antibody at delivery ...... group B streptococcal disease.
@en
Maternal antibody at delivery ...... group B streptococcal disease.
@nl
P2093
P2860
P356
P1476
Maternal antibody at delivery ...... group B streptococcal disease.
@en
P2093
Carol J Baker
Dennis L Kasper
Marcia A Rench
Morven S Edwards
Richard Platt
Sharon L Hillier
Vincent J Carey
P2860
P304
P356
10.1093/INFDIS/JIT549
P407
P577
2013-10-16T00:00:00Z